谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Novel Strategy for RAS-pathway Targeting: Initial Results from a Phase 1b/2 Clinical Trial of the Oral HDAC Inhibitor Bocodepsin (OKI-179) Combined with Binimetinib in Patients with RAS-pathway Mutated Solid Tumors and NRAS-mutated Melanoma

Rodabe N. Amaria,Herbert Duvivier,Katy Tsai, Robert Galamaga,Parisa Momtaz,Evan Pisick, Natalie Langr, Harish Dave,Duncan Walker,Jennifer Diamond,Kevin Litwiler,Ryan Sullivan

MOLECULAR CANCER THERAPEUTICS（2023）

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要